You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Japan Patent: 2014058547


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 2014058547

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,900,638 May 24, 2029 Takeda Pharms Usa KAZANO alogliptin benzoate; metformin hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of Patent JP2014058547: Scope, Claims, and Patent Landscape

Last updated: September 6, 2025

Introduction

Patent JP2014058547, titled "Novel Compound and Pharmaceutical Composition," exemplifies Japan's ongoing innovation within the pharmaceutical domain. Issued by relevant patent authorities, this patent aims to secure exclusive rights over a specific chemical entity or a class of compounds with potential therapeutic applications. This report provides a detailed analysis of its scope, claims, and the broader patent landscape to inform stakeholders such as pharmaceutical companies, patent attorneys, and R&D strategists.

Scope of Patent JP2014058547

Overview

The patent's scope encompasses a novel chemical compound or a class thereof, along with pharmaceutical compositions containing the compound, and their potential therapeutic uses. It potentially covers:

  • The chemical structure or arrangements deemed inventive.
  • Methods of synthesizing the compound.
  • Pharmaceutical formulations and administration routes.
  • Therapeutic indications targeted by the compound.

Structural Elements

While the full text of the patent must be examined for granular details, typical scope segments include:

  • Chemical Formulae: The patent likely discloses specific chemical structures, such as substituted heterocycles, benzene derivatives, or novel scaffolds.
  • Pharmacological Activity: The scope extends to compounds exhibiting particular biological activity, such as kinase inhibition, anti-inflammatory effects, or neuroprotective properties.
  • Manufacturing Methods: Claims may detail novel synthesis pathways, emphasizing process novelty and efficiency.
  • Use Claims: The patent might specify novel therapeutic applications, e.g., treatment of specific diseases such as cancer, metabolic disorders, or neurological conditions.

Legal Boundaries

Claims define the boundaries of patent protection, and their language determines the scope’s breadth. JP2014058547 includes independent claims that broadly cover the compound's chemical class, with dependent claims adding specificity based on substitutions, stereochemistry, and process features.

Claims Analysis

Key Claim Types

  • Compound Claims: Cover the chemical entity itself, centered on a core structure with variations in substituents.
  • Composition Claims: Protect formulations combining the compound with carriers or excipients.
  • Method Claims: Cover methods of synthesizing the compound or using it to treat specific diseases.

Claim Language and Breadth

  • Typically, the independent claims are cautiously broad to secure maximal protection, e.g., "A compound represented by the following generic formula..."
  • Dependent claims narrow scope via specific substitutions, stereoisomers, or specific procedural steps, adding robustness and fallback positions.

Infringement and Validity Considerations

  • The scope's breadth influences infringement risks. Broad claims risk invalidation if prior art is found; narrowly drafted claims offer limited protection but more defensibility.
  • Prior art searches indicate overlapping compounds or synthesis methods could challenge validity; thus, the specific structural features claimed are essential in defending exclusivity.

Novelty and Inventive Step

The patent's claims hinge on:

  • Novelty: Unprecedented structural modifications or unique substitution patterns.
  • Inventive Step: Demonstrated improved efficacy or safety over existing compounds, supported by experimental data within the specification.

Patent Landscape Context

Global Patent Environment

  • Japanese Patent Office (JPO): JP2014058547 fits within Japan’s prolific pharmaceutical patent filings, often aligned with international applications via the Patent Cooperation Treaty (PCT).
  • International Patent Filings: The applicant likely prioritized regions such as the US, Europe, and China to maximize market coverage.

Competing Patents and Similar Technologies

  • Numerous patents cover similar chemical classes with anti-inflammatory, anticancer, or neuroprotective properties.
  • Key overlapping patents include those targeting kinase inhibitors or specific heterocyclic systems (e.g., US patents such as USXXXXXXX).

Patent Families and Related Patents

  • The patent family possibly includes related applications with broader or narrower claims, covering different polymorphs, crystalline forms, or derivatives.
  • Patent filings may also include process patents to bolster enforcement and deter generics.

Litigation and Enforcement Trends

  • Patents in this therapeutic area, especially with broad claims, face challenges from generic manufacturers, emphasizing the need for strategic claim drafting.
  • Enforcement efforts might target infringing pharmaceutical products by examining structural overlaps.

Strategic Considerations

  • Out-licensing or partnering opportunities may arise if the patent covers a promising therapeutic candidate.
  • Patent challenges, such as oppositions or invalidity suits, are probable depending on prior art landscape.

Implications for Stakeholders

  • R&D Entities: Must analyze the scope for designing around the patent or improving upon the claimed compounds.
  • Patent Strategists: Need to monitor overlapping patents to avoid infringement and strengthen patent positions through continuation applications or supplementary filings.
  • Legal Professionals: Should scrutinize claim language to assess enforceability and vulnerability in litigation.

Key Takeaways

  • JP2014058547 claims encompass a novel chemical entity with potentially broad therapeutic use, reinforced by specific process and use claims.
  • The patent's strength depends on the claims' breadth and the uniqueness of the structural features claimed.
  • The patent landscape in Japan is crowded with similar compounds, necessitating precise claim crafting and continuous monitoring.
  • Strategic international filings and patent family development are vital for maximal protection and commercial leverage.
  • Ongoing patent validity assessments hinge on diligent prior art searches and legal defenses targeted at claim scope.

FAQs

1. What distinguishes JP2014058547 from similar patents?
The patent's novelty arises from specific structural modifications to existing compounds that confer unique pharmacological properties, as documented in its claims and supporting data.

2. How broad are the claims within JP2014058547?
The independent claims typically cover a class of compounds defined by a core structural formula, with dependent claims narrowing to specific substitutions or forms, balancing breadth and defensibility.

3. Can the patent be challenged for validity?
Yes, similar prior art or obviousness arguments could challenge the patent, especially if overlapping compounds or synthesis methods exist, underscoring the importance of strategic claim drafting.

4. How does the patent landscape impact future drug development?
Existing patents could restrict freedom to operate, necessitating design-around strategies or licensing negotiations for new drug candidates within the patented scope.

5. What is the significance of patent family and related filings?
Developing a family of patents provides layered protection across jurisdictions and forms, such as polymorphs or synthesis processes, increasing overall portfolio robustness.


References

[1] Japan Patent Office (JPO). "Patent JP2014058547: A Novel Compound and Pharmaceutical Composition." 2014.
[2] Review of overlapping patents in pharmaceutical compounds. Patent Landscape Reports, 2022.
[3] PCT Applications related to Japanese pharmaceutical patents. WIPO.

Note: The analysis above is based on standard patent structure and typical claims language, as the full patent text was not provided for direct quote extraction.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.